🇺🇸 FDA

Intelligence · Clinical Pipeline

Regeneron UK Pipeline

All ClinicalTrials.gov programs at Regeneron UK — phase, modality, and trial IDs.

Programs
126

Quick answer

Regeneron UK has 126 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. REGN1033

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  2. REGN1033

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  3. REGN1033 (SAR391786)

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  4. REGN10933+REGN10987

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  5. REGN1154 or placebo

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  6. REGN1193

    Regeneron UK Limited

    Diabetes Mellitus, Type 2

    phase 1 small molecule terminated

    1 trial

  7. REGN1193

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  8. REGN13335

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  9. REGN1400

    Regeneron UK Limited

    Cancer

    phase 1 small molecule completed

    1 trial

  10. REGN14284

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  11. REGN1500

    Regeneron UK Limited

    Metabolic Disorders

    phase 1 small molecule completed

    1 trial

  12. REGN1500

    Regeneron UK Limited

    Hypertriglyceridemia

    phase 1 small molecule completed

    1 trial

  13. REGN15160 (IV)

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  14. REGN17092

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  15. REGN1908-1909

    Regeneron UK Limited

    Allergy

    phase 1 small molecule completed

    2 trials

  16. REGN2009

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  17. REGN20423

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule active

    1 trial

  18. REGN20934

    Regeneron UK Limited

    Overweight or Obesity

    phase 1 small molecule active

    1 trial

  19. REGN2176-3

    Regeneron UK Limited

    Neovascular Wet Age-related Macular Degeneration (AMD)

    phase 1 small molecule completed

    1 trial

  20. REGN22044

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule active

    1 trial

  21. REGN2222

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  22. REGN2222(SAR438584)

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  23. REGN2477

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  24. REGN2810

    Regeneron UK Limited

    Melanoma

    phase 1 small molecule completed

    1 trial

  25. REGN2810

    Regeneron UK Limited

    Advanced Malignancies

    phase 1 small molecule terminated

    1 trial

  26. REGN2810

    Regeneron UK Limited

    Recurrent Squamous Cell Carcinoma of Head

    phase 1 small molecule completed

    1 trial

  27. REGN3470-3471-3479

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  28. REGN3500

    Regeneron UK Limited

    Asthma, Allergic

    phase 1 small molecule completed

    1 trial

  29. REGN3500

    Regeneron UK Limited

    Asthma

    phase 1 small molecule completed

    1 trial

  30. REGN3500

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  31. REGN3767

    Regeneron UK Limited

    Malignancies

    phase 1 small molecule completed

    1 trial

  32. REGN3918

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  33. REGN421(SAR153192)

    Regeneron UK Limited

    Advanced Solid Malignancies

    phase 1 small molecule completed

    1 trial

  34. REGN4461

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  35. REGN4659

    Regeneron UK Limited

    Carcinoma, Non-Small-Cell Lung

    phase 1 small molecule terminated

    1 trial

  36. REGN475 (SAR164877)

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial

  37. REGN5069

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  38. REGN5093-M114

    Regeneron UK Limited

    Advanced NSCLC

    phase 1 small molecule terminated

    1 trial

  39. REGN5381

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  40. REGN5678

    Regeneron UK Limited

    Prostate Cancer

    phase 1 small molecule active

    1 trial

  41. REGN5713-5714-5715

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  42. REGN6490

    Regeneron UK Limited

    Healthy Volunteer

    phase 1 small molecule terminated

    2 trials

  43. REGN6569

    Regeneron UK Limited

    Squamous Cell Carcinoma of Head and Neck

    phase 1 small molecule terminated

    1 trial

  44. REGN668

    Regeneron UK Limited

    Healthy

    phase 1 mab completed

    1 trial

  45. REGN668

    Regeneron UK Limited

    Dermatitis

    phase 1 mab completed

    1 trial

  46. REGN668: Injection Rate 1

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  47. REGN7257

    Regeneron UK Limited

    Severe Aplastic Anemia (SAA)

    phase 1 small molecule terminated

    1 trial

  48. REGN727

    Regeneron UK Limited

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Regeneron UK have?

126 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.